Multicenter Clinical Evaluation of the (1->3) -D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Measurement of (1-->3)-beta-D-Glucan (BG) has emerged as an adjunct diagnostic strategy for invasive fungal infections (IFI). METHODS: Subjects at 6 clinical sites in the United States were enrolled as either fungal infection-negative subjects (n = 170) or subjects with proven or probable IFI according to European Organization for the Research and Treatment of Cancer/Mycoses Study Group criteria (n = 163). A central laboratory and 4 sites performed assays. A single sample was obtained per patient and was evaluated using an assay to detect serum BG derived from fungal cell walls (range, 0 to > 7000 pg/mL). RESULTS: At a cutoff of 60 pg/mL, the sensitivity and specificity of the assay were 69.9% and 87.1%, respectively, with a positive predictive value (PPV) of 83.8% and a negative predictive value (NPV) of 75.1%. At a cutoff value of 80 pg/mL, the sensitivity and specificity were 64.4% and 92.4%, respectively, with a PPV of 89% and an NPV of 73%. Of the 107 patients with proven candidiasis, 81.3% had positive results at a cutoff value of 60 pg/mL, and 77.6% had positive results at a cutoff value of 80 pg/mL. Of the 10 patients with aspergillosis, 80% had positive results at cutoff values of 60 and 80 pg/mL. The 3 subjects diagnosed with Fusarium species had positive results at a cutoff value of 60 pg/mL. Patients infected with Mucor or Rhizopus species (both of which lack BG) had negative results at both cutoff values, and of the 12 patients with Cryptococcus infection, 3 had positive results at a cutoff value of 60 pg/mL, and 2 had positive results at a cutoff value of 80 pg/mL. Of the subjects with proven positive results who were receiving antifungal therapy (n = 118), 72.9% had results positive for BG at a cutoff value of 60 pg/mL, and 69.5% had results positive for BG at a cutoff value of 80 pg/mL. The interlaboratory sample test r2 was 0.93. CONCLUSION: Reproducible assay results with high specificity and high PPV in a multicenter setting demonstrate that use of an assay to detect serum BG derived from fungal cell walls is a useful diagnostic adjunct for IFI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sensitivity and specificity have been estimated to be 69.9 and 87.1%, respectively [47], as there are a high number of false positive results.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [47]
In the citing paper
“(1 ?3)-b-D-glucan is a component of the cell wall of many fungi and has been proposed as a non-specific marker for invasive fungal infections.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [47]
In the citing paper
“b-1, 3-D-Glucan detection has also been evaluated in critically ill patients, with sensitivity and specificity for diagnosis of IC estimated to be 69.9% and 87.1%, respectively.63”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [63]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 3×
“Subjects. Subjects without IFI and subjects with proven or probable IFI (determined according to the European Organization for the Research and Treatment of Cancer/Mycoses Study Group [EORTC/MSG] criteria [ 15 ]) from 6 clinical sites in the United States consented to participate in this study, and a single blood samp…”
MethodSelf-citation(2012) · Hepatogastroenterology · doi:10.5754/hge11801 · Cited by 802
Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H., & Ostrosky-Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 642 · cited 4×
“The reactivity of the Fungitell assay with Pachyman standard is lower than that of the Fungitec-G assay [9].”
BackgroundMethodSelf-citationObayashi, T., Kawai, T., Yoshida, M., Mori, T., Goto, H., Yasuoka, A., Shimada, K., Iwasaki, H., Teshima, H., Kohno, S., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91152-9 · Cited by 530
Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States
Ostrosky-Zeichner, L., Rex, J. H., Pappas, P. G., Hamill, R. J., Larsen, R. A., Horowitz, H. W., Powderly, W. G., Hyslop, N., Kauffman, C. A., Cleary, J., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3149-3154.2003 · Cited by 498 · cited 1×
“parapsilosis [19].”
Self-citationThe use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
Horvath, J. A., & Dummer, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89455-7 · Cited by 323 · cited 1×
“of cases of invasive aspergillosis [4].”
The New Fungal Opportunists Are Coming
Perfect, J. R., & Schell, W. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s112 · Cited by 224 · cited 1×
“critical care [1].”
Miyazaki, T., Kohno, S., Mitsutake, K., Maesaki, S., Tanaka, K., Ishikawa, N., & Hara, K. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.12.3115-3118.1995 · Cited by 204
Digby, J., Kalbfleisch, J. H., Glenn, A., Larsen, A. R., Browder, W., & Williams, D. L. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.5.882-885.2003 · Cited by 153 · cited 2×
“[18] observed low specificity for fungal infections in a study involving 46 subjects in intensive care units.”
BackgroundMolecular mechanism of hemolymph clotting system in Limulus
Iwanaga, S., Miyata, T., Tokunaga, F., & Muta, T. (1992) · Thrombosis Research · doi:10.1016/0049-3848(92)90124-s · Cited by 133 · cited 1×
“BG produced by fungi [6] is detected by a glucan assay on the basis of its recognition by the innate immune system of horseshoe crabs, specifically Tachypleus tridentatus and Limulus polyphemus [7].”
Background
Research works printed but not linked: 1
- Nakao, 1997, Hepato-gastroenterology, 44, 1413
Cited by
Items 501–600 of 667
T Cell Depleted Haploidentical Transplantation: Positive Selection
Aversa, F. (2011) · Pediatric Reports · doi:10.4081/pr.2011.s2.e14 · Cited by 3
Hedayati, M. T., Khodavaisy, S., & Aliyali, M. (2010) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 5
Nouveaux marqueurs pour le diagnostic de la maladie fongique invasive
Poissy, J., Parmentier-Decrucq, E., Sendid, B., Mathieu, D., & Poulain, D. (2014) · Réanimation · doi:10.1007/s13546-014-0866-4 · Cited by 3
Infections in Solid Organ Transplant Recipients
Husain, S., & Rotstein, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-77674-3_12 · Cited by 3
Fungal Infections in Cancer Patients
Granwehr, B. P., & Kontoyiannis, D. P. (2021) · Springer eBooks · doi:10.1007/978-3-319-74698-2_121-2 · Cited by 4
Mucormycoses post-traumatiques à Lichtheimia corymbifera : à propos de 3 cas
Lambert, D., Nerot, C., Huguenin, A., Diallo, S., Mzabi, A., Ohl, X., Noel, V., Rouger, C., Strady, C., Villena, I., et al. (2014) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2014.10.013 · Cited by 3
Seitz, T., Hoepler, W., Neuhold, S., & Wenisch, C. (2019) · Case Reports in Infectious Diseases · doi:10.1155/2019/3021742 · Cited by 3
Gurguí, M., & Cuenca‐Estrella, M. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76586-8 · Cited by 6
Maschmeyer, G. (2008) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2008.00308.x · Cited by 3
The patient with candidemia: Treatment choices and algorithms
Pappas, P. G. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0017-z · Cited by 3
Self-citationPerfect, J. R. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000399605.75891.fc · Cited by 4
Goto, T., Takata, T., Sato, E., Tamura, K., & Yanase, T. (2013) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.87.39 · Cited by 3
Invasive Conidiobolomycosis Can Be Successfully Treated on Burn Survivors
Ramírez, J. I., & Maguiña, P. (2016) · Journal of Burn Care & Research · doi:10.1097/bcr.0000000000000365 · Cited by 3
Enfermedades invasoras por hongos levaduriformes en pacientes neutropénicos
Ruíz-Camps, I., & Jarque, I. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2015.11.001 · Cited by 4
Gastrointestinal and Hepatic Complications of Solid Organ and Hematopoietic Cell Transplantation
Larson, A. M., & McDonald, G. B. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00034-2 · Cited by 3
Allergic Bronchopulmonary Aspergillosis
Sebat, C. M., Avdalovic, M. V., & Morrissey, B. M. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6836-4_13 · Cited by 3
Aguilar-Zapata, D. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae514 · Cited by 2
“D -glucan appears to have greater value as a screening assay rather than a diagnostic assay because of its low positive predictive value [9].”
BackgroundRen, S., Xu, P., Dai, M., Chen, R., & Tang, H. (2025) · Respirology Case Reports · doi:10.1002/rcr2.70239 · Cited by 2
Boán, J., Fernández‐Ruiz, M., Aparicio‐Minguijón, E., & Aguado, J. M. (2025) · Journal of Fungi · doi:10.3390/jof11120853 · Cited by 2
Post-Cardiac Surgery Fungal Endocarditis
Badiee, P. (2012) · InTech eBooks · doi:10.5772/25432 · Cited by 3
Kaba, H. E. J., Maier, N., Schliebe-Ohler, N., Mayer, Y., Müller, P., van den Heuvel, J., Schuchhardt, J., Hanack, K., & Bilitewski, U. (2014) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2014.11.003 · Cited by 4
Choi, H., Kim, C. J., Kim, M. S., Shin, B. S., & Na, C. H. (2019) · Annals of Dermatology · doi:10.5021/ad.2019.31.5.571 · Cited by 2
Updates on the Treatment of Non-Aspergillus Hyaline Mold Infections
Nematollahi, S., & Shoham, S. (2019) · Current Fungal Infection Reports · doi:10.1007/s12281-019-00364-4 · Cited by 2
Hyalohyphomycosis: Infection Due to Hyaline Moulds
Hospenthal, D. R. (2015) · Springer eBooks · doi:10.1007/978-3-319-13090-3_11 · Cited by 2
Kalita, B., Roy, A., Jayaprakash, A., Annamalai, A., & Velan, L. P. T. (2023) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2023.2265414 · Cited by 2
“…is an enzyme required for strengthening of the fungal cell wall during cell wall biogenesis through chitin-glucan (β-1–6) crosslinking (Arroyo et al. 2016) which is crucial for cell wall integrity as it was evident that the Rhizopus species lacks β-1,3-glucans (Ostrosky-Zeichner et al. 2005).”
BackgroundDiagnosis of Invasive Fungal Disease
Neofytos, D., & Marr, K. A. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-644-3_23 · Cited by 2
Die serologische Diagnostik von Pilzinfektionen
Lass‐Flörl, C. (2007) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-007-0472-0 · Cited by 2
“Ein Nachteil des Tests ist die Unfähigkeit zwischen der Pilzgattung zu unterscheiden [8, 9].”
BackgroundDefining Invasive Aspergillosis: What the Revised EORTC/MSG Definitions Have in Store
Donnelly, J. P. (2009) · Springer eBooks · doi:10.1007/978-90-481-2408-4_25 · Cited by 2
Xu, W.-M., Shui, W., Lin, J., Lin, Z.-Q., Li, M., Xing, Y.-L., & Zhang, C.-R. (2014) · Medical Mycology · doi:10.1093/mmy/myu068 · Cited by 2
“Studies have shown that, when different methods and boundary values were properly used, the diagnosis of candidemia has a high sensitivity (64%–90%) and specificity (73%–100%), with a negative predictive value as high as 73%–97% [14,15].”
MethodZaragoza, R., Llinares, P., Maseda, E., Ferrer, R., & Rodríguez, A. H. (2013) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2013.05.016 · Cited by 3
Espondilodiscitis fúngica, sus manifestaciones clínicas y su tratamiento
Hernández, G. C., Buitimea, C. J. V., & Uribe, E. V. (2013) · Orthotips AMOT · Cited by 2
Soler, N., Huerta, A. H., & Torres, A. (2011) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0b013e31822182b2 · Cited by 2
“Reproducible assay results, with high specificity and high positive predictive value, demonstrated that use of an assay to detect serum [1-3]-b-D-glucan derived from fungal cell walls might be a useful diagnostic tool for invasive pulmonary infection.(43) A single case of positive [1-3]-b-D-glucan values during fatal…”
Aspergillose pulmonaire invasive chez le patient immunocompétent en réanimation
Chebib, N., Delsuc, C., Sénéchal, A., & Ader, F. (2013) · Réanimation · Cited by 2
Mendoza, D. P., Castillo, E., Alrabaa, S. F., Murtagh, R. D., Velez, A. P., Yacoub, A. T., Khwaja, S. I., & Greene, J. N. (2013) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000111 · Cited by 2
Azimi, S., SABOKBAR, A., Bairami, A., & Gharavi, M. J. (2019) · Iranian Journal of Parasitology · doi:10.18502/ijpa.v14i2.1140 · Cited by 2
Elevated level of beta-D-glucan in Pseudomonas infection
Shrestha, K. L., & Kadkhoda, K. (2024) · IDCases · doi:10.1016/j.idcr.2024.e01931 · Cited by 2
“…diseases and the associated high morbidity and mortality, this culture-independent diagnostic tool can significantly enhance clinical outcomes, particularly in critically ill patients where obtaining tissue samples can be problematic and fungal cultures may not always be sensitive enough [2].”
BackgroundAspergillose pulmonaire invasive chez le patient immunocompétent en réanimation
Chebib, N., Delsuc, C., Senechal, A., & Ader, F. (2013) · Médecine Intensive Réanimation · doi:10.1007/s13546-013-0686-7
Fungal Infections in Neutropenic Patients
Gea‐Banacloche, J., Groll, A. H., & Walsh, T. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_28 · Cited by 2
Bakri, M. M. (2011) · Otago University Research Archive (University of Otago) · Cited by 2
Ostrosky‐Zeichner, L., & Finkelman, M. (2006) · Clinical Infectious Diseases · doi:10.1086/501131 · Cited by 2
Self-citationBiomarkers in fever and neutropenia: A solution in search of a problem?*
Gea‐Banacloche, J. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31820f6d6d · Cited by 2
Problems and recent advances in measurement of (1→3)-β-D-glucan
Yoshida, K., Shoji, H., & Niki, Y. (2008) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.49.75 · Cited by 2
Erratum to: An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2014) · Infection · doi:10.1007/s15010-013-0577-x · Cited by 2
Fungal Infections After Hematopoietic Cell Transplantation
Marr, K. A. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch86 · Cited by 2
Invasive Candidiasis in the Intensive Care Unit
Krishnan, S., & Ostrosky-Zeichner, L. L. (2010) · Hospital Practice · doi:10.3810/hp.2010.04.298 · Cited by 2
Self-citationWade, J. C. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_52 · Cited by 1
“[183] [184] [185] .”
Invasive Pulmonary Aspergillosis in Critically Ill Apparently Immunocompetent Patients
Rishi, A. R., Sethi, I., Jesinger, M. E., Beddawi, Y., Morehead, R. S., & Khosravi, M. (2016) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000161 · Cited by 2
Infections fongiques en réanimation
Soulier-Zaninka, Q., Lefebvre, T., Bayart, G., Viart, C., Tarpin, P., & Dupont, H. (2024) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2023.11.003 · Cited by 1
Daryani, D., Lybik, N., & Saffo, S. (2025) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2025.2549386 · Cited by 1
“Furthermore, because beta-D-glucan is not a primary cryptococcal cell wall component, other non-invasive tests suchas beta-D-glucan assays lack efficacy for detecting cryptococcal infections and are associated with additional shortcomings, limiting their role in this context [29].”
Kuhara, Y., Kitagawa, H., Tadera, K., Omori, K., Shigemoto, N., Akita, T., Fukuma, S., Takahashi, S., & Ohge, H. (2026) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-026-05446-z · Cited by 1
Norkin, M. N., & John, R. (2011) · InTech eBooks · doi:10.5772/22537 · Cited by 1
“of most molds, but especially Zygomycosis is challenging given the difficulty of extracting fungal elements from infected tissues [59] Because of numerous limitations related to culture techniques, adjunctive non-cultural methods such as galactomannan (GM) antigen, b-(1-3)-D glucan (BG) and PCR-based methods are now b…”
BackgroundDonor-Derived Infectious Complications and Disease Transmission
Chan, K., & Lee, W. (2012) · InTech eBooks · doi:10.5772/30784 · Cited by 1
“Presently, the 1-3, beta-d-glucan assay is probably the most reliable, with a sensitivity and specificity of 70% and 87%, respectively, among patients who have proven invasive candidiasis (Obayashi et al., 2008; Ostrosky-Zeichner et al., 2005).”
BackgroundStrategien bei Versagen einer antimykotischen Therapie auf Intensivstation
Arens, C., Bernhard, M., Koch, C., Heininger, A., Störzinger, D., Hoppe‐Tichy, T., Hecker, M., Grabein, B., Weigand, M. A., & Lichtenstern, C. (2015) · Der Anaesthesist · doi:10.1007/s00101-015-0072-0 · Cited by 1
Fungal Thoracic Spondylodiskitis in an Immunocompetent 14-year-old Girl
Asano, T., Hatori, T., Kuwabara, K., Aki, K., & Fujino, O. (2009) · Journal of Nippon Medical School · doi:10.1272/jnms.76.265 · Cited by 1
Sanz, M. Á., de la Cámara, R., Jarque, I., López, J., Madero, L., Ruíz-Camps, I., Vázquez, L., & Vallejo, C. T. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76382-1 · Cited by 1
1–3 β-D-glucan: From Diagnosis to Prognosis
Richards, E. P., Mohammadi, S., & Forrest, G. N. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0118-6 · Cited by 1
Antifungal therapy: current concepts and evidence-based management
Perfect, J. R., & Andes, D. R. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761136 · Cited by 1
Arıkan-Akdağlı, S., Azap, A., Demirkazık, F., Ener, B., Hayran, S. A., Kumbasar, Ö. Ö., Metan, G., Odabaşı, Z., Uzun, Ö., & Akan, H. (2014) · Turkish Journal of Hematology · doi:10.4274/tjh.2014.0218 · Cited by 1
Machetti, M., & Marchese, A. E. (2009) · Microbiologia medica · doi:10.4081/mm.2009.2544 · Cited by 1
ESCMID/ECMM Joint Clinical Guideline for the Diagnosis and Management of Rare Invasive Yeast
Arendrup, M. C., Boekhout, T., Akova, M., & Cornely, O. A. (2013) · Cited by 1
Harada, S., Hatakeyama, S., Kitazawa, T., Itoyama, S., Yasuo, O. T. A., & Koike, K. (2009) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.83.538 · Cited by 1
Fungal Infections in Solid Organ Transplant Recipients
Pappas, P. G. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_30 · Cited by 1
Self-citationPistiki, A. C., Τσαγανός, Θ., Tsangaris, I., Antonakos, N., Damoraki, G., & Giamarellos‐Bourboulis, E. J. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2728-3 · Cited by 1
The Role of Biomarkers for Starting Antifungals in the Intensive Care Unit
Pagani, J., Revelly, J., Que, Y., & Eggimann, P. (2015) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000118 · Cited by 1
Central Nervous System Infections
Zimmer, A. J., Burke, V. E., & Bloch, K. C. (2016) · ASM Press eBooks · doi:10.1128/9781555819040.ch24 · Cited by 1
Fungal Infections in Cancer Patients
Granwehr, B. P., Sipsas, N. V., & Kontoyiannis, D. P. (2019) · Springer eBooks · doi:10.1007/978-3-319-74588-6_121 · Cited by 1
Boucher, H. W., & Patterson, T. F. (2015) · Springer eBooks · doi:10.1007/978-3-319-13090-3_10 · Cited by 1
Zhang, S. X., & Wiederhold, N. P. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0030-2016 · Cited by 1
“Thus, a positive result can Yeasts be caused by various fungal infections, including those caused by yeasts and molds (167, 169 – 171).”
BackgroundRinaldi, S., & Gaudio, A. R. D. (2009) · Springer eBooks · doi:10.1007/978-88-470-1436-7_24 · Cited by 1
Traboulsi, R. S. (2009) · CRC Press eBooks · doi:10.3109/9780849387869-17 · Cited by 1
Wingard, J. R. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-478-0_30 · Cited by 1
Self-citationMicosis en pacientes inmunocomprometidos
Oñate-Gutiérrez, J. M. (2022) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2022.05.031 · Cited by 3
Boucher, H. W., & Patterson, T. F. (2023) · Springer eBooks · doi:10.1007/978-3-031-35803-6_11 · Cited by 2
Effects of Different Container Types on (1→3)-β-D-glucan Recovery
Burgmaier, L., Illes, B., Leiß, M., Avci‐Adali, M., & Reich, J. (2023) · Molecules · doi:10.3390/molecules28196931 · Cited by 1
“For glucan detection, factor C is removed from the lysate, allowing the remaining factor G to initiate the cascade upon encountering (1 → 3)- β -D-glucans [9].”
Critically Ill Surgical Patients in the Intensive Care Unit
Coloretti, I., & Girardis, M. (2024) · Updates in surgery/Updates in surgery series · doi:10.1007/978-3-031-60462-1_17 · Cited by 1
Endobronchial mucormycosis successfully treated with pharmacologic therapy: A rare case report
Jung, S. K., & Choi, K.-J. (2025) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2025.102232 · Cited by 1
Management of Invasive Candidiasis in the Critically Ill
Garnacho‐Montero, J., Díaz‐Martín, A., & Márquez-Vácaro, J. A. (2012) · Springer eBooks · doi:10.1007/978-3-642-25716-2_30 · Cited by 2
樊, 新. (2014) · Medical Diagnosis · doi:10.12677/md.2014.43005 · Cited by 1
Antifungals in pulmonary infections: to whom, when and how?
Ott, S. R. (2017) · European Respiratory Society eBooks · doi:10.1183/2312508x.10005316 · Cited by 1
Hirano, M., Ota, Y., Koibuchi, T., Takei, T., Takeda, R., Kawamata, T., Yokoyama, K., Uchimaru, K., Yotsuyanagi, H., Imai, Y., et al. (2018) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2018.379 · Cited by 1
Detecting Invasive Fungal Disease in Surgical Patients: Utility of the (13)- β- d -Glucan Assay
Skubic, J. J., Taghavi, S., Castillo‐Angeles, M., Ramsis, R., Salim, A., & Askari, R. (2020) · Surgical Infections · doi:10.1089/sur.2019.247 · Cited by 2
“A BDG assay level ‡80 pg/mL was used as the cutoff for an elevated level as established in previous studies [15,16].”
Aspergillus as a Human Pathogen: an Evolutionary Perspective
Mellado, E., Cuenca‐Estrella, M., & Rodríguez-Tudela, J. L. (2014) · ASM Press eBooks · doi:10.1128/9781555815639.ch49 · Cited by 1
Pharmacokinetics of voriconazole in horses and alpacas
Chan, H. M. (2008) · Cited by 1
Papel de anidulafungina en el paciente crítico
Borges-Sa, M., & Garnacho‐Montero, J. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76591-1 · Cited by 1
Update on invasive fungal infections: the last two years
Lumbreras, C., Álvarez-Lerma, F., Carreras, E., Cisneros, J. M., Garnacho, J., Martín‐Mazuelos, E., Pemán, J., Quindós, G., Rubio, C., Torre‐Cisneros, J., et al. (2007) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(07)75789-0 · Cited by 1
Démarche diagnostique et prise en charge des infections fongiques chez les patients immunodéprimés
Botterel, F. (2007) · Antibiotiques · doi:10.1016/s1294-5501(07)88765-6 · Cited by 2
1468Detection of High CSF Levels of (1 → 3)-Beta-D-Glucan in Cryptococcal Meningitis
Rhein, J., Bahr, N. C., Morawski, B. M., Schutz, C., Finkelman, M., Meya, D. B., Meintjes, G., & Boulware, D. R. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu052.1014 · Cited by 1
Self-citationINFECTIONS IN PEDIATRIC LUNG TRANSPLANTATION
Hoffman, J. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50087-x · Cited by 1
Anesi, J. A., & Amorosa, V. (2016) · Springer eBooks · doi:10.1007/978-3-319-33341-0_34 · Cited by 1
Maschmeyer, G. (2014) · Springer eBooks · doi:10.1007/978-3-662-44000-1_10 · Cited by 1
Opportunistic Infections in Pediatric Blood and Marrow Transplantation
Dvorak, C. C., & Steinbach, W. J. (2013) · Pediatric oncology · doi:10.1007/978-3-642-39920-6_6
Controversies in Empiric Therapy of Febrile Neutropenia
Wingard, J. R. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-644-3_9
Self-citationHyalohyphomycosis—Infection Due to Hyaline Moulds
Fleming, R. V., & Anaissie, E. J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-325-7_10
Infectious Etiologies of Altered Consciousness
Roos, K. L. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01711-3
The 2008 EORTC/MSG consensus definitions: What’s new? What’s next?
Almyroudis, N. G., & Segal, B. H. (2009) · Current Fungal Infection Reports · doi:10.1007/s12281-009-0027-5 · Cited by 1
Rubio, M. C., Rezusta, A., Gil, J., Benito, R., & Revillo, M. J. (2007) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13111837
Pathogens in Severe Sepsis: New Paradigms for Fungi Treatment
Bassetti, M., & Mikulska, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03519-7_11
Polymerase Chain Reaction (PCR)–Based Diagnostic Assays for Invasive Candidiasis
Clancy, C. J., & Nguyen, M. H. (2011) · Current Fungal Infection Reports · doi:10.1007/s12281-011-0062-x
Ader, F. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0025-7
“The main limitation of this test is the detection of whole fungal agents, so that complementary tests are needed to define the fungal agent responsible for the disease [59, 60].”
BackgroundTreatment of invasive aspergillosis in cancer patients
Auberger, J., Russ, G., Greil, R., & Egle, A. (2011) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-011-0304-1
Metadata
- Authors
- Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., Finkelman, M. A., & Rex, J. H.
- Affiliations
- Duke University (US)
- University of Miami (US)
- University of Alabama at Birmingham (US)
- Seikagaku Corporation (Japan) (JP)
- University of Florida Health (US)
- College of Idaho (US)
- AstraZeneca (United Kingdom) (GB)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 41
- Issue
- 5
- Pages
- 654-659
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2127508258
- Cited by
- 669
- References
- 26
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 12 · 2023: 14 · 2022: 7 · 2021: 15 · 2020: 16 · 2019: 25 · 2018: 25 · 2017: 21 · 2016: 38 · 2015: 29 · 2014: 50 · 2013: 42 · 2012: 39
- FWCI
- 29.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- β-1,3-glucan, invasive fungal infections, fungal infection diagnosis, candidiasis, aspergillosis, Fusarium, Mucor, Rhizopus, Cryptococcus, antifungal therapy, sensitivity and specificity, cut-off values, interlaboratory agreement, serum biomarkers, EORTC/MSG criteria
- MeSH terms
- Adult, Aged, Female, Humans, Male, Middle Aged, Mycoses, Proteoglycans, Sensitivity and Specificity, Reproducibility of Results, beta-Glucans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.